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Richard Cooper, Sujata Jinagouda, and Steven Shea
AJH 2004; 17:963–970Background: Most previous studies investigating the
association between ethnicity and hypertension focused on
differences between African Americans and whites and did
not include other racial/ethnic groups such as Chinese or
Hispanics.
Methods: We used data from the Multi-Ethnic Study of
Atherosclerosis (MESA), a population-based study of
6814 adults without clinical cardiovascular disease, to
examine the association between ethnicity and hyperten-
sion and hypertension treatment among white, African
American, Chinese, and Hispanic ethnic groups.
Results: The prevalence of hypertension, defined as
systolic blood pressure (BP) 140 mm Hg and diastolic
BP 90 mm Hg or self-reported treatment for hyperten-
sion, was significantly higher in African Americans com-
pared to whites (60% v 38%; P  .0001), whereas
prevalence in Hispanic (42%) and Chinese participants
(39%) did not differ significantly from that in whites. After
adjustment for age, body mass index, prevalence of dia-
betes mellitus, and smoking, African American (odds ratio
[OR] 2.21; 95% confidence interval [95% CI] 1.91–2.56)
and Chinese (OR 1.30; 95% CI 1.07–1.56) ethnicity were
significantly associated with hypertension compared toology and Preventive Medicine, UCLA School of Medicine (SJ), Los
© 2004 by the American Journal of Hypertension, Ltd.
Published by Elsevier Inc.whites. Among hypertensive MESA participants, the per-
centage of treated but uncontrolled hypertension in whites
(24%) was significantly lower than in African Americans
(35%, P  .0001), Chinese (33%, P  .003), and Hispan-
ics (32%, P  .0005), but only African-American race/
ethnicity remained significantly associated with treated but
uncontrolled hypertension after controlling for socioeco-
nomic factors (OR 1.35; 95% CI 1.07–1.71). Diuretic use
was lowest in the Chinese (22%) and Hispanic participants
(32%) and was significantly lower in these groups com-
pared with white participants (47%; P  .0001 for both
comparisons).
Conclusions: Programs to improve hypertension
treatment and control should focus on a better understand-
ing of differences in the prevalence of hypertension and
hypertension control among minority groups in the United
States, especially African Americans, compared with
whites, and on techniques to prevent hypertension and
improve control in high-risk groups. Am J Hypertens
2004;17:963–970 © 2004 American Journal of Hyperten-
sion, Ltd.
Key Words: Race, ethnicity, hypertension, hyperten-
sion control, MESA.T he detection, treatment, and control of hyperten-sion have contributed substantially to the decline incardiovascular mortality in many developed coun-
tries in the past 30 years. However, the decline in cardio-
vascular deaths in the United States has not been
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amining factors associated with BP differences between
ethnic groups has demonstrated that education, income,
and financial stress all influence BP.6–9 However, the
majority of such studies focused on African American/
white differences and did not include Asian or Hispanic
ethnic groups and therefore did not reflect the changing
demographics of the United States. Moreover, few studies
have examined whether use of different classes of antihy-
pertensives vary by racial/ethnic group. In light of the
Joint National Committee on the Detection, Evaluation,
and Treatment of High Blood Pressure guidelines, which
recommend diuretics as initial therapy for most patients
with hypertension,10 it is important to determine whether
certain racial/ethnic groups are more likely to be treated
with diuretics than others.
The Multi-Ethnic Study of Atherosclerosis (MESA), a
study of the characteristics of subclinical cardiovascular
disease in white, African-American, Chinese, and His-
panic adults, provides an opportunity to compare the in-
dependent association between ethnicity and the presence
of hypertension and hypertension treatment and control
among men and women without established cardiovascu-
lar disease. Because hypertensive individuals without es-
tablished cardiovascular disease would be targeted for the
primary prevention of cardiovascular disease, we also
examined whether use of different classes of antihyperten-
sives differs by racial/ethnic group.
Methods
Study Population
The MESA investigation is a population-based study of
6814 men and women age 45 to 85 years, without clinical
cardiovascular disease, recruited from six United States
communities (Baltimore, MD; Chicago, IL; Forsyth
County, NC; Los Angeles County, CA; northern Manhat-
tan, NY; and St. Paul, MN). The main objective of MESA
is to determine the characteristics of subclinical cardiovas-
cular disease and its progression. Sampling and recruit-
ment procedures have been previously described in
detail.11 Adults with symptoms or history of medical or
surgical treatment for cardiovascular disease were ex-
cluded. During the recruitment process, potential partici-
pants were asked about their race/ethnicity. Questions on
race/ethnicity were based on the U.S. 2000 census ques-
tionnaire. Subjects who self-reported their racial/ethnic
group as white or Caucasian, black or African-American,
Chinese, or Spanish/Hispanic/Latino were asked to partic-
ipate. Race/ethnicity was then categorized as white (non-
Hispanic), African-American (non-Hispanic), Chinese,
and Hispanic. Subjects were enrolled between August 1,
2000, and July 30, 2002. Institutional Review Board ap-
proval was obtained at all MESA sites.BP, Hypertension, and Treatment
All MESA subjects completed self-administered question-
naires and were interviewed by trained research staff to
collect information pertaining to demographic character-
istics, medical history, medication, alcohol, and tobacco
use. These self-administered questionnaires were available
in English, Spanish, and Chinese. Trained and certified
clinic staff obtained BP and anthropometric measurements
on all MESA participants during the baseline visit. After a
5-min rest BP was measured three times at 1-min intervals
using a Dinamap PRO 100 automated oscillometric device
(Critikon, Tampa, FL) with the subject in a seated position
with the back and arm supported.12 The average of the
second and third BP measurements was used for this
analysis. Diagnosis of hypertension was defined as self-
reported treatment for hypertension with one of six com-
mon classes of antihypertensive medications (thiazide
diuretics, -blockers, calcium channel blockers, angioten-
sin-converting enzyme inhibitors (ACEI), angiotensin-2
receptor blockers (ARB), and other (-blockers or periph-
eral vasodilators) or a systolic BP 140 mm Hg or dia-
stolic BP 90 mm Hg. Hypertension control was defined
as systolic BP 140 mm Hg and diastolic BP 90 mm Hg
among patients who reported treatment for hypertension
with one of the six classes of antihypertensive medica-
tions. Acknowledged but untreated hypertension was de-
fined as the participant reporting a previous physician
diagnosis of hypertension but not taking antihypertensive
medication. Participants with a systolic BP 140 mm Hg
or diastolic BP 90 mm Hg who reported no previous
physician diagnosis of hypertension on the questionnaire
were defined as being unaware of their hypertension.
Covariates
Presence of diabetes mellitus (DM) was based on self-
reported physician diagnosis, use of insulin and/or oral
hypoglycemic agent, or a fasting glucose value 126
mg/dL at the MESA baseline examination. Alcohol intake
(average number of drinks per week) and current smoking
status were based on self-report. Height was measured to
the nearest 0.1 cm with the subject in stocking feet and
weight was measured to the nearest pound with the subject
in light clothing using a balanced scale. Body mass index
(BMI) was calculated as weight in kilograms divided by
height in meters squared.
Information on socioeconomic factors including high-
est degree or level of school completed, total household
income, financial strain, use of medical services, and
health insurance was collected from the MESA partici-
pants using questionnaires. The total household income
included money from jobs, net income from business,
farm or rent, pensions, dividends, welfare, social security
payments, and any other income received by the partici-
pant and all household members living with the partici-
pant. Participants were instructed to choose 1 of 13 income
categories that best represented the total family income for
965AJH–October 2004–VOL. 17, NO. 10 RACE/ETHNICITY AND HYPERTENSION TREATMENT AND CONTROLthe past 12 months. To estimate mean income, the mid-
point of the range for each category was used. For the
highest category income ($100,000 and higher), $120,000
was assigned. Financial strain was defined as the partici-
pant responding “Yes” to the question, “Has ongoing
financial strain been a problem for you?” The question-
naire also inquired whether the participant used a primary
care clinic versus the emergency room for routine health
care services. Health insurance status was also ascertained
(private health insurance, HMO, Medicaid, Medicare, Vet-
eran’s health care, or none).
Statistical Analysis
Means and standard deviations were used to summarize
the characteristics of the study sample. Continuous vari-
ables were compared using ANOVA, and categorical vari-
ables were compared using the 2 statistic. When
comparing racial/ethnic groups, ANOVA was used to as-
sess differences of continuous variables among the four
racial/ethnic groups. If the ANOVA test was significant,
all non-white racial/ethnic groups were compared with
whites. We set the level for statistical significance at P 
.017 (.05/3) to account for multiple comparisons (whites
versus three racial/ethnic groups).
Multivariate logistic regression was used to examine
the association between racial/ethnic group and hyperten-
sion in the entire MESA population. Several different
logistic regression models were examined so that changes
in the parameter estimate with the addition of demo-
graphic and socioeconomic factors could be examined.
Covariates for these models were selected based on pre-
viously published reports.6–8,13–16 Model 1 adjusted for
age and sex, whereas model 2 added BMI, waist circum-
ference, alcohol consumption, current tobacco use, and
presence of DM to model 1. Model 3 added education,
income, and financial strain to model 2. In all logistic
regression models, age, BMI, waist circumference, and




Age (y)* 63.1 (10.3) 6
Female (%) 52.0
SBP (mm Hg)* 123.5 (20.4) 13
DBP (mm Hg)* 70.2 (10.0) 7
HTN (%)† 38
BMI (kg/m2)* 27.7 (5.1) 3
DM (%) 7
Current smoker (%) 12
BMI  body mass index; DBP  diastolic blood pressure; DM  dia
All racial/ethnic groups compared with whites.
* Results are shown as mean (standard deviation); † Hypertens
antihypertensive medications (thiazide diuretics,  blockers, calcium
sin-2 receptor blockers, and  blockers) or a SBP 140 mm Hg or DB
ethnic group comparisons with white ethnicity .017.alcohol consumption were fitted as continuous variablesand current smoking, DM, and reported financial strain
were included as binary variables (yes/no). Education was
categorized as completion of grades 0 to 8, 9 to 11, high
school or technical school, Associate degree or some col-
lege, or college degree or higher (reference group). House-
hold income was divided into five categories ($25,000,
$25,000 to $50,000, $50,000 to $75,000, $75,000 to
$100,000, and $100,000) and was included in the
model with $100,000 as the reference group.
We also examined the association between racial/ethnic
group and treated but uncontrolled hypertension among all
MESA participants with treated hypertension. In addition
to the three models used for the regression analysis of
hypertension, we included a fourth model, which added
use of a primary care clinic versus use of emergency room
for acute illness, presence of health insurance versus none,
and use of diuretics (yes/no). Effect modification between
ethnicity and sex, education, income, and financial strain
on hypertension and on treated but uncontrolled hyperten-
sion was examined by adding interaction terms to the
multivariate models, which included all of the covariates.
Results
A total of 6814 men and women (38% white, 28% African
American, 12% Chinese, 22% Hispanic) between the ages
of 45 and 85 years completed the first MESA examination.
The majority of both whites and African Americans re-
ported being born in the United States or Puerto Rico
(90%), whereas 96% of Chinese and 58% of Hispanics
reported being born outside the United States. Among the
Hispanics born outside the United States or Puerto Rico,
birthplace was reported as Mexico in 43%, Dominican
Republic in 20%, South America in 15%, Central America
in 7%, and other countries in 15%. The characteristics of
the MESA participants by racial/ethnic group are shown in








(10.0) 62.9 (10.3) 61.8 (10.4)‡
.5 51.4 51.9
(21.6)‡ 124.6 (21.6) 126.7 (21.9)‡
(10.2)‡ 72.0 (10.3)‡ 71.5 (10.1)‡
‡ 39 42
(5.9)‡ 24.0 (3.3)‡ 29.4 (5.1)‡
‡ 14‡ 19‡
‡ 6‡ 13
mellitus; SBP  systolic blood pressure.
TN) defined as self-reported treatment with one of six classes of
nnel blockers, angiotensin-converting enzyme inhibitors, angioten-























































































































































































































































































































































































































































































































































































































































































































































































































































































































































966 AJH–October 2004–VOL. 17, NO. 10RACE/ETHNICITY AND HYPERTENSION TREATMENT AND CONTROLhigher among African Americans and Hispanics compared
with whites. Hypertension was noted in 38% of whites,
60% of African Americans, 39% of Chinese participants,
and 42% of Hispanics. Compared with whites, the preva-
lence of hypertension was higher in African Americans (P
 .0001), whereas no significant difference was noted
between white and Chinese (P  .78) participants. The
frequency of hypertension was higher among Hispanics
compared with whites but the difference did not reach
statistical significance after accounting for multiple com-
parisons (P  .026) (the level for statistical significance
was set at P  .017 (.05/3) to account for multiple com-
parisons as stated in the Statistical Analysis section).
The characteristics of the subjects by racial/ethnic
group and by presence of hypertension are listed in Table
2. Hypertensive individuals were significantly older, had
higher BMI and waist circumference, and were more
likely to have DM compared with normotensives in each
racial/ethnic group. Normotensives reported approxi-
mately 25% higher mean total household income com-
pared with hypertensives except among whites where
normotensives reported 19% higher income compared
with hypertensives. The lowest reported household income
was noted among the Chinese and Hispanic participants
with hypertension. In each racial/ethnic group, the per-
centage of adults who graduated from high school was
lower among adults with hypertension compared with
normotensive adults. This difference was significant in all
ethnicity groups (P  .004 for whites; P  .0001 for
African Americans; and P  .0046 for Hispanics) except
the Chinese (P  .018). The lowest percentage of subjects
who completed high school was noted among Hispanics
with 51% and 58% in hypertensives and normotensives,
respectively.
Figure 1 shows the percentage of treated and controlled
or uncontrolled hypertension, and acknowledged but un-
treated hypertension among hypertensive MESA partici-
pants by racial/ethnic group. The prevalence of
hypertension was not calculated by national origin among
the Hispanic MESA participants due to the small numbers
in several of the groups. The characteristics of the MESA
participants by racial/ethnic group are listed in Table 1.
The percentage of treated but uncontrolled hypertension
among whites (24%) was significantly lower than African
American (35%, P  .0001), Chinese (33%, P  .003),
and Hispanic (32%, P  .0005) MESA participants. Ac-
knowledged but untreated hypertension ranged from 6% in
African Americans to 8% in Hispanics and did not differ
among the four racial/ethnic groups. The African Ameri-
cans had a significantly lower percentage of men and
women who were unaware of their hypertension compared
with whites (13% v 23%; P  .0001), whereas no differ-
ence was noted between the white and Chinese and white
and Hispanic participants.
Table 3 lists the class of current antihypertensive med-
ications reported among the treated hypertensive MESA
participants with the percentage using each class as mono- T A % B W % % % T A i t
967AJH–October 2004–VOL. 17, NO. 10 RACE/ETHNICITY AND HYPERTENSION TREATMENT AND CONTROLtherapy in parentheses. Compared with whites, use of
diuretics was significantly lower in the Chinese (22% v
47%; P  .0001) and Hispanic participants (32% v 47%;
P  .0001). Among African Americans, -blocker use
was significantly lower (18% v 28%; P  .0001) and
calcium channel blocker use was significantly higher (40%
v 25%; P  .0001) compared with whites. Use of -block-
ers among the Chinese and Hispanic participants did not
differ significantly from whites. Use of calcium channel
blockers was higher among Hispanics than whites (33% v
25% P  .0025), but differences in calcium channel
blocker use between Chinese and white participants did
FIG. 1. Treatment and control of hypertension (HTN) among hy-
pertensive MESA participants by race and ethnicity. Hypertension
defined as self-reported treatment with one of six classes of antihy-
pertensive medications (thiazide diuretics, -blockers, calcium
channel blockers, angiotensin-converting enzyme inhibitors, angio-
tensin-2 receptor blockers, and -blockers) or a systolic BP 140
mm Hg or diastolic BP 90 mm Hg. 1P  .0001 compared with
whites, 2P  .001 compared with whites, 3P  .01 compared with
whites. Treated and controlled hypertension: whites  Hispanics3.
Treated and uncontrolled hypertension: African Americans 
whites1; Hispanics  whites2; and Chinese  whites3. Unaware of
hypertension: whites  African Americans1.






Calcium channel blocker 25% (7%)
ACEI/ARB 52% (21%)
Other† 8% (1%)




ACEI  angiotensin-converting enzyme inhibitor; ARB  angiotens
All ethnic groups compared to whites.
§P  .001 compared to whites;
* Data are shown as percentage of treated hypertensives using an
as monotherapy in parentheses. Monotherapy drug use was not com
vasodilators, -blockers; ‡ P  .0001 compared to whites;  P  .01 comnot reach statistical significance (P  .049). The ACEI/
ARB use was similar across the white, African American,
and Hispanic racial/ethnic groups, whereas among Chi-
nese MESA participants, use (40%) was significantly
lower than whites (52%; P  .002). Use of ACEI/ARB
surpassed use of all other classes of antihypertensives
among the racial/ethnic groups except among African
Americans where use of ACEI/ARB and diuretics was
similar.
Table 4 lists the results of the logistic regression models
examining the association between racial/ethnic group and
presence of hypertension (use of antihypertensives or BP
140/90 mm Hg). In all models, African American race/
ethnicity was associated with more than a twofold higher
odds of hypertension compared with whites. The age- and
sex-adjusted odds ratio (OR) was 2.72 (95% confidence
interval [95% CI] 2.38–3.10) and adjustment for all the
covariates including income and financial strain reduced
the OR to 2.21 (95% CI 1.91–2.56). The Chinese racial/
ethnic group was not associated with presence of hyper-
tension in the age- and sex-adjusted model compared with
whites. After the addition of demographic factors includ-
ing BMI (model 2), Chinese race/ethnicity was associated
with a 42% (95% CI 1.17–1.71) higher odds of hyperten-
sion compared with whites. Adjustment for education,
income, and financial strain reduced the OR to 1.30 (95%
CI 1.07–1.56). In contrast, Hispanic race/ethnicity was
associated with the presence of hypertension in the age-
and sex-adjusted model (1.31; 95% CI 1.14–1.50) but this
association was no longer significant after adjustment for
the other covariates. No significant interaction was ob-
served between race/ethnicity and sex, education, income,
and financial strain on odds of hypertension in the regres-
sion model that included all of the covariates (model 3).
Results of the regression models for treated but uncon-
trolled hypertension (BP 140/90 mm Hg) are listed in








% (11%) 22%‡ (6%) 32%‡ (6%)
‡ (4%) 34% (10%) 25% (9%)
‡ (13%) 32% (15%) 33% (13%)
% (13%) 40% (17%) 53% (21%)
% (1%) 9% (0.5%) 8% (1%)
17% 9% 14%
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ethnicity were all associated with increased odds of treated
but uncontrolled hypertension in model 1 (sex and age)
and model 2 (model 1 and BMI, waist circumference,
presence of DM, smoking, and alcohol consumption) com-
pared with whites. After the addition of education level,
income, and financial strain to the regression model, the
association between Chinese and Hispanic race/ethnicity
and treated but uncontrolled hypertension was no longer
statistically significant. However, African-American race/
ethnicity remained significantly associated with treated but
uncontrolled hypertension in all the regression models,
including model 4, which added use of emergency room
for primary care services, lack of health insurance, and use
of diuretics (OR 1.35; 95% CI 1.07–1.71). No significant
interactions were noted between race/ethnicity and di-
uretic use, sex, education, income, and financial strain on
odds of treated but uncontrolled hypertension.
Discussion
In this cross-sectional analysis of adults without estab-
lished cardiovascular disease, we noted a significantly
higher prevalence of hypertension among African Amer-
icans compared with whites, but no significant difference
in the prevalence of hypertension between white and His-
panic or white and Chinese racial/ethnic groups. The







95% CI  95% confidence interval.
Model 1 includes age and sex.
Model 2 includes model 1 and BMI, waist circumference, presenc
Model 3 includes model 2 and education level, income and financ
Hypertension (use of antihypertensive medications or BP 140/9






White 1.00 (Reference) 1.00 (R
African-American 1.49 (1.19–1.84) 1.44 (1
Chinese 1.58 (1.15–2.17) 1.55 (1
Hispanic 1.64 (1.27–2.11) 1.58 (1
CI  confidence interval; other abbreviations as in Tables 1 and 4.
Treated but uncontrolled hypertension  SBP 140 or DBP 90 a
Model 1 includes age and sex.
Model 2 includes model 1 and BMI, waist circumference, presenc
Model 3 includes model 2 and education level, income, financial s
Model 4 includes model 3 and use of emergency room for primary carehigher prevalence of hypertension among African-Amer-
ican MESA participants compared with white participants
is similar to reports in the general U.S. population.17 The
most recent National Health and Nutrition Examination
Survey (NHANES), conducted in 1999 to 2000 also
showed a significantly higher prevalence of hypertension
among non-Hispanic African American adults (34% v
29%; P  .01) compared with whites. The older age of the
MESA participants probably accounts for the higher prev-
alence of hypertension compared with the NHANES sur-
vey, which included adults 18 years of age.
The frequency of hypertension was higher among His-
panics compared with whites but the difference did not
reach statistical significance after accounting for multiple
comparisons (P  .026). The higher frequency of hyper-
tension among Hispanics compared with whites contrasts
with the most recent NHANES results, which noted a
significantly lower prevalence of hypertension among
Mexican Americans (21% v 29%; P  .001) compared
with whites.17 It is important to note that more than half of
the Hispanic MESA participants were not born in Mexico.
In addition, mean BMI and prevalence of DM were sig-
nificantly higher among the Hispanic MESA participants
compared with white participants, and this could account
for the excess hypertension noted among the Hispanics.
Moreover, the association between Hispanic ethnicity and





1.00 (reference) 1.0 (reference)
2.33 (2.01–2.69) 2.21 (1.91–2.56)
1.42 (1.17–1.71) 1.30 (1.07–1.56)
1.12 (0.97–1.30) 0.92 (0.81–1.14)
M, and current smoking status.
rain to model 2.
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–2.05) 1.22 (0.91–1.63) 1.19 (0.89–1.60)
g treated hypertensives.














trainservices, lack of health insurance, and use of diuretics.
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waist circumference, and presence of DM.
In China, the prevalence of hypertension in the adult
population age 35 to 74 years ranges from 34% among
adults living in northern China to 27% in southern
China.18 However, the majority of hypertensives in China
are not treated and less than 30% receiving antihyperten-
sive treatment are controlled (systolic BP 140 mm Hg
and diastolic BP 90 mm Hg).18 Previous national sur-
veys of hypertension in the United States did not include
Chinese-Americans, a population with limited data on
hypertension prevalence. Stroke rates in Asian countries
such as China, Korea, and Japan are two- to fivefold
higher compared with U.S. rates in large part due to
undertreatment or no treatment for hypertension.18,19 It is
likely that social factors, such as diet, continue to influence
BP levels among Chinese-Americans, especially because
the vast majority of Chinese MESA participants were born
outside the United States.
Compared with whites, all non-white racial/ethnic
groups were significantly associated with treated but un-
controlled hypertension. The NHANES noted significantly
lower rates of hypertension control among both African
American (45%; P  .05) and Mexican American adults
(44%; P  .05) compared with whites (56%).17 A popu-
lation-based survey of elderly men and women living in
North Carolina noted that African Americans were 67%
more likely than whites to have uncontrolled BP after
adjustment for multiple covariates.20 The association be-
tween Chinese and Hispanic race/ethnicity and treated but
uncontrolled hypertension did not remain significant after
the addition of socioeconomic factors including education
level, income, and financial strain, which suggests that
these factors influence hypertension control. In contrast,
the association between African-American race/ethnicity
and uncontrolled hypertension was attenuated after adjust-
ment for multiple covariates but remained statistically
significant, consistent with the interpretation that these
factors as well as others indexed by African-American
race/ethnicity influence hypertension control. One such
factor is likely to be higher pretreatment BP levels. This
hypothesis is supported by several previous large cohort
studies such as the Multiple Risk Factor Introduction Trial
and the Hypertension Detection and Follow-Up Program,
which noted significantly higher pretreatment BPs in Af-
rican Americans compared with whites.21,22 The majority
of hypertensive MESA participants were receiving antihy-
pertensive treatment; thus, this cross-sectional study can-
not determine whether pretreatment BPs differ by racial/
ethnic group. Regarding differential treatment, diuretic use
was lowest among Chinese and Hispanic participants and
highest among African Americans compared with whites.
Mean household income was lowest among Chinese and
Hispanic participants with hypertension, yet these two
ethnic groups were least likely to be treated with diuretics,
the lowest cost class of antihypertensives.The MESA study was designed to investigate the prev-alence and progression of subclinical cardiovascular dis-
ease in a large sample of men and women without known
cardiovascular disease. Thus, the MESA participants are
not representative of the U.S. population of people with
hypertension, which includes those with known cardiovas-
cular disease. However, many of our findings are sup-
ported by studies based on representative samples of the
U.S. population.17 In addition, this multiracial cohort with-
out established cardiovascular disease represents the pa-
tient population targeted for the primary prevention of
cardiovascular disease, and the diversity of the MESA
participants provides information on racial/ethnic groups
not included in previous studies.
In conclusion, we noted an association between Afri-
can-American and Chinese race/ethnicity and hyperten-
sion compared with whites after controlling for multiple
covariates. In addition, the prevalence of treated but un-
controlled hypertension was significantly higher among
African-American, Chinese, and Hispanic racial/ethnic
groups compared with whites. Use of diuretics, the most
affordable class of antihypertensives and first-line therapy
for the treatment of uncomplicated hypertension,10 was
lowest in groups with very limited monetary resources.
These data indicate areas of health services research that
deserve continued attention and research.
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